Press Releases
Press Releases
Eyevensys appoints Dr Ivan Cohen-Tanugi as CEO
Eyevensys, a company developing a new non-viral gene therapy process to treat ocular illnesses that enables prolonged production of all therapeutic proteins through electrotransfer, today announces the appointment of Dr Ivan Cohen-Tanugi as CEO.ย ...
Press Releases
Med Opportunity Partners, LLC Makes Strategic Investment in Pfanstiehl, Inc.
Med Opportunity Partners LLC (โMEDOPโ) a Greenwich CT-based private equity firm focused exclusively on the health care sector announced today its acquisition of Ferro Pfanstiehl Laboratories Inc. a global leader in cGMP carbohydrates and Active Pharmaceutical Ingredients (APIs)...
Press Releases
Innovatix to Exhibit at Inaugural National Association of Specialty Pharmacy Conference
Innovatix LLC the nationโs leading non-acute care group purchasing organization (GPO) will be exhibiting at the inaugural National Association of Specialty Pharmacy (NASP) Conference next week April 2-3 at the Manchester Grand Hyatt in San Diego. ...
Press Releases
Oncodesign signs a partnership agreement and an option for exclusive licensing with Sanofi in the area of tissue protection and repair
Oncodesign, a company specializing in drug discovery and providing pharmacological evaluation services in the field of oncology, today announces that it has signed a second research collaboration agreement with Sanofi.ย This partnership follows a...
Press Releases
GLOBAL BIOENERGIES receives 740,000 euros from OSEO to create a pre-industrial strain
Global Bioenergies the industrial biology company that develops sustainable routes to light olefins announces a new 740000 euros financing from OSEO a French SME-funding state agency to support the creation of an isobutene production strain compatible with industrial...
Press Releases
Curie-Cancer trebles early phase clinical research studies with industry partners
Curie-Cancer, the body responsible for developing Institut Curieโs industry partnership activities, today announces a strong increase in the number of early stage clinical trials (phase I) from three in 2010 to ten in 2012. The studies are being...
Press Releases
Luke Johnson, leading entrepreneur, takes the helm at The Institute of Cancer Research
Luke Johnson, one of the UKโs most successful entrepreneurs and former Chairman of Channel 4, has been appointed as Chairman of The Institute of Cancer Research, London. Johnson runs private equity firm Risk Capital...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















